The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, open-label study to evaluate the safety and pharmacokinetics of the anti ErbB3 antibody, KTN3379, alone or in combination with targeted therapies in patients with advanced tumors.
 
Todd Michael Bauer
Research Funding - Kolltan Pharmaceuticals (Inst)
 
Jeffrey R. Infante
Research Funding - Kolltan Pharmaceuticals (Inst)
 
Joseph Paul Eder
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - MedImmune
 
Patricia LoRusso
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Genentech; Novartis
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst); Immunogen (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tensha Therapeutics (Inst)
 
Theresa LaVallee
Employment - Kolltan Pharmaceuticals
Leadership - Kolltan Pharmaceuticals
Stock and Other Ownership Interests - Kolltan Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Kolltan Pharmaceuticals
Travel, Accommodations, Expenses - Kolltan Pharmaceuticals
 
Rich Gedrich
Employment - Kolltan Pharmaceuticals
Stock and Other Ownership Interests - Kolltan Pharmaceuticals
 
Carolyn Sidor
Employment - Kolltan Pharmaceuticals
Leadership - Kolltan Pharmaceuticals
Stock and Other Ownership Interests - Kolltan Pharmaceuticals
Consulting or Advisory Role - Kolltan Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Kolltan Pharmaceuticals
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Research Funding - ARMO BioSciences; AstraZeneca; Celgene; EMD Serono; Genmab; GlaxoSmithKline; Incyte; Kolltan Pharmaceuticals; MedImmune; Millennium; Novartis; Vegenics
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - EMD Serono; Millennium; Sarah Cannon Research Institute